Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tim Roy Cressey

19PUBLICATIONS

112CO-AUTHORS

Adolescent healthPharmacogenomicsInfant and child healthNeonatologyEpidemiological methods

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Feb 24, 2026

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Carlos Grasa, Nicolas Salvadori, Alessandra Nardone

|Dec 29, 2025

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).

Adrie Bekker, Navarat Panjasawatwong, Louise F Hill

|Sep 06, 2025

Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV Infection.

Ahmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry

|Jul 31, 2025

Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s study.

Marije Van Schalkwyk, Adrie Bekker, Eric Decloedt

|May 29, 2025

Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.

Helena Rabie, Dwight E Yin, Shawn Ward

|Feb 20, 2025

Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir Study.

Tim R Cressey, Nicolas Salvadori, Helena Rabie

Pageof 4

Frequent Collaborators

4 joint publications

Nicolas Salvadori

3 joint publications

Kulkanya Chokephaibulkit

2 joint publications

Gonzague Jourdain

2 joint publications

Adrie Bekker

1 joint publications

Vera E Bukkems

1 joint publications

Nicole Ngo-Giang-Huong

1 joint publications

Natedao Kongyai

1 joint publications

Prasert Auewarakul

1 joint publications

Romanee Chaiwarith

1 joint publications

Surinda Kawichai

Frequent Collaborators

4 joint publications

Nicolas Salvadori

3 joint publications

Kulkanya Chokephaibulkit

2 joint publications

Gonzague Jourdain

2 joint publications

Adrie Bekker

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on : Aug 12, 2020

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on : Aug 12, 2020

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos